DNA methylation analysis of tumor suppressor genes in liquid biopsy components of early stage NSCLC: a promising tool for early detection.
Athina N MarkouD LondraV TserpeliΙ KolliasE TsarouchaI VamvakarisK PotarisI PaterasΑ KotsakisV GeorgouliasΕ LianidouPublished in: Clinical epigenetics (2022)
DNA methylation of these five gene promoters was significantly lower in CTCs and plasma-cfDNA than in the primary tumors. Combination of DNA methylation analysis in CTC and plasma-cfDNA was associated with worse DFI of NSCLC patients. Additional studies are required to validate our findings in a large cohort of early stage NSCLC patients.
Keyphrases